World Health Organization site
Skip Navigation Links

Main
Note: This record shows only 22 elements of the WHO Trial Registration Data Set. To view changes that have been made to the source record, or for additional information about this trial, click on the URL below to go to the source record in the primary register.
Register: ClinicalTrials.gov
Last refreshed on: 16 October 2023
Main ID:  NCT03547050
Date of registration: 24/05/2018
Prospective Registration: Yes
Primary sponsor: King's College London
Public title: Rolandic Epilepsy Genomewide Association International Study REGAIN
Scientific title: Rolandic Epilepsy Genomewide Association International Study
Date of first enrolment: June 1, 2018
Target sample size: 210
Recruitment status: Completed
URL:  https://clinicaltrials.gov/ct2/show/NCT03547050
Study type:  Observational
Study design:   
Phase: 
Countries of recruitment
Argentina Canada Greece Italy Spain United Kingdom United States
Contacts
Key inclusion & exclusion criteria

Inclusion Criteria:

1. Diagnosis of Rolandic Epilepsy in accordance with the following international
criteria:

- Age of first afebrile seizure 3-12 years

- Seizures comprising focal sensorimotor seizures affecting the vocal tract and
face, with or without involvement of the arm

- Predominant sleep-related seizures

- EEG interictal centro-temporal spikes with normal background

2. Current age 6-25 years

Exclusion Criteria:

1. No history of focal seizure

2. Normal EEG or abnormal background features on EEG

3. Known structural causes (stroke, tuberous sclerosis, infection, post-infectious or
metabolic)

4. Primary diagnosis of autism or global learning disability

5. Focal central neurological deficit on clinical exam,

6. Unable to provide informed consent

7. Unable to provide blood sample



Age minimum: 6 Years
Age maximum: 25 Years
Gender: All
Health Condition(s) or Problem(s) studied
Rolandic Epilepsy
Intervention(s)
Other: Blood draw
Other: Existing samples
Primary Outcome(s)
Allelic association p value corrected for genome wide testing [Time Frame: Day 1]
Secondary Outcome(s)
Secondary ID(s)
TWF 164-3020
229844
Source(s) of Monetary Support
Please refer to primary and secondary sponsors
Secondary Sponsor(s)
Hasbro Children's Hospital
Guy's and St Thomas' NHS Foundation Trust
Cardiff University
Aghia Sophia Children's Hospital of Athens
Hospital Mutua de Terrassa
King's College Hospital NHS Trust
Columbia University
Hospital JP Garrahan
Seattle Children's Hospital
The Hospital for Sick Children
Ethics review
Results
Results available:
Date Posted:
Date Completed:
URL:
Disclaimer: Trials posted on this search portal are not endorsed by WHO, but are provided as a service to our users. In no event shall the World Health Organization be liable for any damages arising from the use of the information linked to in this section. None of the information obtained through use of the search portal should in any way be used in clinical care without consulting a physician or licensed health professional. WHO is not responsible for the accuracy, completeness and/or use made of the content displayed for any trial record.
Copyright - World Health Organization - Version 3.6 - Version history